
Abstract
Bernard Soulier syndrome is a rare hereditary macrothrombocytopenia, with an incidence of <1 per million.
Patients may have variable platelet counts, ranging from <10 × 109/L to normal, as well as variable clinical expressions of a hemorrhagic phenotype.
The defect lies mainly in primary hemostasis, and consists of a qualitative or quantitative deficiency of the glycoprotein (GP) Ib-IX-V complex, which interacts with the von Willebrand factor (VWF) adhered on exposed subendothelial collagen. The GP Ib-IX-V complex also has a role in platelet activation induced by thrombin
and in the binding of coagulation factor XI to the platelet surface.
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more